Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine for Nasal CPAP Pain in Preterm Infants
NCT02268968Phase 1Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoint: Premature Infant Pain Profile. Started Oct 2013; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02268968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268968.